Directory · DE
Biotechnology Research in Germany
A register of firms and the professionals working at them in the Biotechnology Research sector based in Germany. Browse the public index, then filter or export on Kipplo.
Companies
1.1K on file
Merck Life Science
Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come. Merck is a global science and technology company with around employees in more than 66 countries. Not intended for US & CA visitors.
10001+ staff
Ab Enzymes
AB Enzymes is an industrial biotech company specialized in enzymes and their applications. The company is part of Associated British Foods and represented worldwide. Our offices are located in Brazil, China Germany, Finland, Singapore and USA. Our products range from food grade enzymes for baking and beverages, grains and vegetable oil seeds processing, to enzymes for animal feed and technical applications: pulp & paper, textiles and laundry detergents. We partner with our diverse and unique customers to support them in their process optimization needs.
201 to 500 staff
Analytik Jena
About Analytik Jena GmbH+Co. KG Analytik Jena is a leading global supplier of analytical measurement and automation technology in the fields of chemical analysis, molecular biology, and liquid handling. Precise results and ease of use are the top priorities in the development of Analytik Jena's laboratory analysis products. Instrument-specific consumables and outstanding customer services and complete the extensive range. Analytik Jena is part of the Endress+Hauser Group, a family-owned company based in Switzerland. Visit our YouTube profile for moving footage
1001 to 5000 staff
Biocytogen
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.
1001 to 5000 staff
Bruker Daltonics
Bruker Life Science Mass Spectrometry is a leading global developer and manufacturer of innovative scientific instruments that address the rapidly evolving needs of a diverse array of life sciences customers. Our mass spectrometry-based tools serve the pharmaceutical, biotechnology, molecular diagnostics research and chemical analysis industries. Bruker's analytical instruments deliver exceptional high-resolution results for pre-clinical and clinical testing. Research institutes, universities and government agencies routinely turn to Bruker for systems that address real world needs. Innovations such as Trapped Ion Mobility (TIMS), smartbeam and scanning lasers for MALDI-MS Imaging that deliver true pixel fidelity, and eXtreme Resolution FTMS (XR) technology capable to reveal Isotopic Fine Structure (IFS) signatures are pushing scientific exploration to new heights. Our mass spectrometry solutions enable scientists to make breakthrough discoveries and gain deeper insights. Bruker's product lines include the following technologies: timsTOF, MRMS, rapifleX® MALDI-TOF/TOF, UHR-QTOF, Triple Quadrupole, HDX Solution, Toxtyper® and TargetScreener HR. Our industry leading software solutions such as SCiLS™ Lab for MS Imaging, MetaboScape® and Biopharma Compass® are examples for our solutions doing the work for you.(For Research Use Only. Not for use in clinical diagnostic procedures)
1001 to 5000 staff
Invivoscribe
Invivoscribe® is a global leader dedicated to Improving Lives with Precision Diagnostics®, advancing the quality of healthcare by providing innovative products and clinical services for oncology. Our Streamlined CDx® (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. With products manufactured in our state-of-the-art cGMP facility, we provide a comprehensive range of platform agnostic assays, reagents, controls and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Invivoscribe’s products consistently surpass industry and regulatory standards and play a crucial role in identifying, stratifying and monitoring hematologic cancers, enabling scientific advancements and empowering clinicians to make informed treatment decisions. Our subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), offers extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, providing results that are critically important for patient care in the U.S, Europe, and Asia. Join us in our mission to revolutionize oncology diagnostics and improve patient outcomes worldwide. Visit our website to discover how Invivoscribe’s ecosystem is driving advancements in precision medicine.
201 to 500 staff
Askbio Inc
AskBio Inc, a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: • Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. • Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. • Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. • Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. • Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.
501 to 1000 staff
Probiogen Ag
ProBioGen is a renowned contract development and manufacturing organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second L single-use bioreactor is coming soon. With 30 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end. Watch & learn more: https://youtu.be/vtEgrEVfj70
201 to 500 staff
Starlab
We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, as well as in companies in the life sciences. We have earned an excellent reputation within the research community as a consultative company who takes a structured approach to Liquid Handling products and support. We work very closely with our customer network to continuously improve the products we offer, and to seek out new opportunities both from a product and support perspective. We have become a significant market player in all the product and service areas where we focus our efforts. Our success is due to our highly-trained and motivated staff and a portfolio of high quality products and services. STARLAB are liquid handling experts, with many years’ experience in automated injection moulding processes for the manufacture and sale of high quality laboratory consumables for research and development. With TipOne® we have developed one of the world's leading pipette tip systems. Quality, price and service are STARLAB’s core principles STARLAB is based in Germany, the United Kingdom, France and Italy, for the direct sales of our extensive product range. In addition, regional partners in many countries allow the purchase of STARLAB products throughout the world.
51 to 200 staff
Dynavax Technologies
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S, the European Union and the United Kingdom for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit and follow Dynavax on LinkedIn. Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.
201 to 500 staff
Hygiena
Hygiena delivers rapid microbial detection, monitoring, and identification solutions to a wide range of industries, including food and beverage, healthcare, hospitality, pharmaceuticals, and personal care. Utilizing advanced technologies and patented designs, Hygiena provides industry-leading ATP monitoring systems, PCR-based pathogen detection and characterization systems, allergen tests, environmental collection devices, and more. Hygiena is committed to the mission of providing customers with high-quality innovative technologies that are easy-to-use and reliable, backed by excellent customer service and support. Headquartered in Camarillo, California with multiple offices around the world including United States, United Kingdom, Spain, Canada, Mexico, Australia, Brazil and China, and over 180 distributors in more than 100 countries worldwide, Hygiena branded products span the globe.
501 to 1000 staff
Artivion, Inc
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
1001 to 5000 staff
Dispendix
WE ARE CREATING THE FUTURE OF HEALTH DISPENDIX provides premium liquid handling technology to scientists and lab technicians around the world, and is creating the future of medicine. Liquid handling technology enables new discoveries in areas such as drug development, diagnostics and synthetic biology. We believe that technological advances and science are made for each other. Good technology simplifies science. DISPENDIX GmbH, the premier provider of noncontact liquid handling solutions in the nano to microliter range, started out in 2016 as a spin-off from the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany. In 2018, DISPENDIX joined the world’s leading bio convergence company BICO, which now encompasses 900+ colleagues and 11 companies, offering a portfolio of technologies, products and services to create the future of health. Part of that portfolio is DISPENDIX’s award winning patented and widely recognized technology, the I.DOT (Immediate Drop-on-demand Technology), which brings intuitive automation, precision and speed to every lab, allowing scientists to optimize liquid handling workflows and accelerate their research in a range of applications.
51 to 200 staff
Formycon Ag
Who we are Formycon AG is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. About Biosimilars: Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection – including 45 blockbusters with an estimated total annual global turnover of more than 200 billion US dollars. Biosimilars are successor products to biopharmaceutical drugs for which market exclusivity has expired. They are approved in highly regulated markets such as the EU, the USA, Canada, Japan and Australia in accordance with strict regulatory procedures. Biosimilars create competition and thus give more patients access to biopharmaceutical therapies. At the same time, they reduce costs for healthcare systems. Global sales of biosimilars currently amount to around 21 billion US dollars. Analysts assume that sales could rise to over 74 billion US dollars by 2030. Contact: Formycon AG Fraunhoferstr. 15 82152 Martinsried/Planegg Germany phone +49 (0) 89 - 86 46 67 100 fax + 49 (0) 89 - 86 46 67 110 info@formycon.com
201 to 500 staff
Gba Group
GBA Group is an international life science services company with over employees and a wide range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water and the environment. The group stands for outstanding technical expertise, efficient processes and full focus on customer benefits with regard to its activities in the fields of research, product development, market development and consumer protection. With its services, GBA Group directly and indirectly makes a sustainable contribution to health, the environment and society.
1001 to 5000 staff
Jpt Peptide Technologies
We are the Peptide Experts! JPT has a large peptide synthesis capacity, providing over 1 million peptides per year. We offer all possible peptide modifications such as macrocyclic peptides, phosphorylated peptides, labeled and tagged peptides, radioligands, isotope labeling and more. Made in Germany Global Support More than 20 Years of Expertise Ethical, Environmental & Health Standards Portfolio: Custom Peptides Our patented technologies in peptide libraries, pools, microarrays, and micro-scale synthesis set us apart as a leader in the field. From micro to large-scale synthesis, our state-of-the-art labs in Germany deliver peptides tailored to your needs. Modified Peptides We produce modified peptides such as long and stapled peptides, dyes, labeled and biotinylated peptides, PTMs, unique building blocks, conjugations, macrocyclic peptides and more. PepMix Peptide Pools Peptide pools for antigen-specific T-cell stimulation in immune monitoring, assay control, cell therapy development, T-cell expansion etc. In addition to custom PepMix peptide pools we have more than 500 PepMixes in stock, for example: Control Pools: CEFX, CEF, Actin, CMV pp65 … Viral Proteins of EBV, SARS-CoV-2, CMV, VZV, HPV … TAA: Prame, NY-ESO-1, MART-1, MAGE A … Clinical Peptides & Pools Our resulting Clinical Grade Peptides have been approved for a variety of clinical applications including immunotherapy and vaccine development, immune monitoring, and clinical proteomics. Please visit our website for more information! JPT Peptide Technologies GmbH Management: Aurélien Claeyssen & Dr. Sierk Poetting Hermann-Dorner-Alle 23, D-12489 Berlin T:+49 30 322980-7878 peptide@jpt.com Registration Court: Berlin / Amtsgericht Charlottenburg, HRB 92692 VAT identification number: DE Imprint: Privacy Policy:
51 to 200 staff
Leniobio
At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry.
11 to 50 staff
Pepperprint Gmbh
PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by researchers around the world with over 200 peer-reviewed publications.
11 to 50 staff
Tetec Tissue Engineering Technologies Ag
Wir setzen neue Maßstäbe in der regenerativen Medizin. Die TETEC AG ist ein Unternehmen der Biotechnologie-Branche und gehört der Octane Medical Group of Companies an. Wir entwickeln und produzieren mit unseren Mitarbeitern, die jeweils in interdisziplinären Teams organisiert sind, am Standort in Reutlingen innovative Produkte zur Behandlung komplexer Schäden und Erkrankungen im Bereich des menschlichen Stütz- und Bewegungsapparates. Wir vereinen Spezialisten aus unterschiedlichen Fachrichtungen und verknüpfen in einzigartiger Weise zell- und molekularbiologisches Wissen mit klinischem und pharmakologischem Know-how.
51 to 200 staff
Tum Campus Straubing
Am TUM Campus Straubing für Biotechnologie und Nachhaltigkeit der Technischen Universität München betreiben Wissenschaftler grundlagenorientierte Forschung und technologische Entwicklungen zu Nachwachsenden Rohstoffen, Biotechnologie und Bioökonomie. Forschungsschwerpunkte sind dabei die chemisch-stoffliche Nutzung und die energetische Verwertung, sowie ökonomische Aspekte rund um die Erzeugung, Vermarktung und Verwendung von Nachwachsenden Rohstoffen. Weitere Forschungsschwerpunkte sind Regenerative Energiesysteme, die Verwertung von Reststoffen, die Tiefen- und oberflächennahe Geothermie sowie Solarenergie. In Forschung und Lehre findet auch der Grundsatz der Nachhaltigkeit besondere Beachtung. Die akademische Ausbildung am TUM Campus Straubing erfolgt im Rahmen mehrerer Bachelor- und Masterstudiengänge und Promotionen.
10001+ staff
Lipotype
We provide Lipidomics analysis service to help you achieve your research goals. Our mass spectrometry-based lipidomics technology identifies and quantifies more than 4200 individual lipids. Our technology works on high throughput scale but requires only minimal sample amounts, and delivers results in as little as two weeks. Life science researchers from biotech and pharma, food industry, cosmetics and dermatology as well as academia fuel their research with Lipotype Lipidomics. Lipotype is a spin-off company from the Kai Simons and Andrej Shevchenko labs of the world-renowned Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden, Germany. Lipotype - Lipidomics for a better life
11 to 50 staff
Nanotemper Technologies
NanoTemper Technologies is deeply committed to the best customer experience. Central to this is a strong focus on high quality products made in Germany that enable researchers to easily, efficiently, and accurately perform protein characterization. With a broad offering of systems, software and consumables for evaluating binding affinities and protein stability, scientists in pharmaceutical, biotech or academic labs will find an optimized workflow, quality results and responsive customer support. Work with a deeply experienced and globally operating team, and realize the NanoTemper experience. Imprint: https://nanotempertech.com/imprint/
201 to 500 staff
Nippon Genetics Europe
Innovation for you! With two decades of experience, NIPPON Genetics EUROPE stands at the forefront of life science and biotechnology innovation. Based in the heart of Europe, we're your global partner in delivering cutting-edge, high-quality products designed to meet the unique needs of the life science sector. Our extensive product lineup is at the cutting edge of technology, featuring instruments such as Real-Time PCR systems, Gel Documentation systems, and spectrophotometers. We're particularly proud of our newest breakthrough: the FastGene® FAS-X Gel Documentation System. Built with our Blue/Green LED technology, it has been honored with the German Innovation Award 2024! But that's not all—we also offer a comprehensive range of reagents for DNA and protein electrophoresis, PCR, cell biology, and more. Our best-selling Bambanker™, a serum-free cell cryopreservation medium, is trusted by researchers worldwide. At NIPPON Genetics EUROPE, we pride ourselves on our exceptional quality standards, customer benefits, and reliability. With a distribution network in over 70 countries, we're dedicated to helping you achieve your scientific goals. Interested in our products or exploring collaboration opportunities? Have a look at our website: or reach out to us at info@nippongenetics.de.
11 to 50 staff
Sino Biological, Inc
Sino Biological is a global leader in recombinant protein and antibody production, gene synthesis, and CRO services for life sciences research and drug development. Its facilities include the Center for Bioprocessing (C4B) in Houston, Texas, which specializes in mammalian cell-based protein and antibody production, and SignalChem Biotech (SCB) in Vancouver, Canada, focusing on kinase-related reagents, stable cell line development, and therapeutic discovery. Sino Biological ensures innovative, high-quality solutions for global academic and industrial clients.
501 to 1000 staff
Zymo Research Europe
From its birthplace in a small garage in Orange, California, to the industry leader it is today, Zymo Research has been led by a vision to have a positive impact in the biomedical field and to contribute to the greater good of humanity. That vision touches every aspect of Zymo Research and has guided the company’s growth, culture and creation of the most innovative and valuable biomedical tools and services since 1994. Zymo Research Europe was established in 2012 and is located in the beautiful city of Freiburg i. Br, in the southernmost part of Germany. Based in the gorgeous scenery of the Black Forest, close to France and Switzerland, Zymo Research Europe serves as a hub fur Europe, Middle East and North Africa as well as a provider for NGS-Services. Zymo Research is a globally established biotechnology company with international facilities and a global distribution network, that enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world. Historically recognized as the leader in epigenetics, the company is breaking boundaries with novel solutions for sample collection, microbiomics analysis, and the emerging Next-Gen Sequencing technologies - driven by the fundamental belief that "the beauty of science is to make things simple."
11 to 50 staff
Affimed
Affimed N.V.(Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company’s Innate Cell Engagers (ICE®), generated from its proprietary ROCK® platform, are bispecific antibodies, which target innate immune cells, e.g. natural killer (NK) cells and macrophages, to destroy tumor cells. Affimed’s ICE® enable a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors with activity demonstrated as monotherapy and when given in combination with NK cells and other I-O therapeutics. Affimed has three active clinical programs focused on solid tumors and blood cancers. The lead candidate Acimtamig (AFM13) is in development for patients with CD30-positive lymphomas. Acimtamig combined with NK cells has demonstrated high objective response rates in heavily pretreated, relapsed / refractory (r/r) Hodkin lymphoma (HL) patients with a manageable safety profile in a clinical trial (AFM13-104). Affimed’s phase 2 study, LuminICE-203, is underway to investigate acimtamig in combination with AlloNK® (also known as AB-101), an off-the-shelf, allogeneic NK cell from Artiva Biotherapeutics, in patients with r/r HL with an exploratory arm planned in patients with r/r/ peripheral T-cell lymphoma (PTCL). AFM24 is in development for epidermal growth factor receptor (EGFR)-expressing solid tumors. Based on the data generated to date, the developmental focus of AFM24 is in combination with the anti-PD-L1 inhibitor atezolizumab in advanced stage EGFR-positive non-small cell lung cancer (NSCLC). AFM28 is being developed for patients with CD123-expressing acute myeloid leukemia (AML) in need of new therapeutic options. A first-in-human Phase 1 clinical study is underway (AFM28-101) and development in combination with allogeneic NK cell therapy is being explored.
51 to 200 staff
Biotype Gmbh
BIOTYPE is an innovative German solution provider for molecular precision diagnostics. We are committed to advancing precision medicine through our products & services for reliable analysis and interpretation of clinical biomarkers. BIOTYPE offers a strong portfolio in molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics and RUO assays for translational and clinical research. In addition, BIOTYPE offers high-quality and IVD-compliant contract development and manufacturing services. Our proprietary MODAPLEX platform is a benchtop system for automated molecular profiling and multi-biomarker testing. MODAPLEX addresses the growing need to simplify and accelerate precision testing by reliably delivering actionable molecular information required for biomarker-guided care in precision medicine. The MODAPLEX consolidates multi-gene testing into one workflow with same-day results. BIOTYPE‘s quality management system is certified according to ISO 9001:2015 & ISO 13485:2016.
51 to 200 staff
Bioweg
BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies.
11 to 50 staff
Canopy Biosciences
Canopy Biosciences, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.
51 to 200 staff
Crelux, A Wuxi Apptec Company
CRELUX, part of WuXi AppTec’s Research Service Division, is a global provider of structure based drug discovery solutions. We have been delivering customized and integrated services in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening, to support small and large molecule, as well as biopharmaceutical drug discovery, for more than a decade. Our mission is to enable our clients to perform their work faster, more efficiently and more successfully. Integrating the comprehensive portfolio of services offered by our parent company WuXi AppTec, CRELUX offers a unique opportunity for our collaborators to accelerate discovery activities. Imprint: CRELUX GmbH Am Haag 16 82166 Graefelfing Germany crelux_info@wuxiapptec.com VAT: Amtsgericht München HRB Managing Directors: Dr. Alex Satz, Dr. Thomas Meins
51 to 200 staff
Cytena
We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other downstream applications. Most of the top ten largest pharmaceutical companies have successfully integrated cytena instruments into their workflows to quickly produce monoclonal cell lines for antibody development with minimal risk of cross-contamination. cytena instruments are also used for academic research for various topics including cancer, autoimmune disease and genomic research. Our instruments provide many benefits including: Assurance of clonality Every single cell isolated is imaged to provide assurance of clonality. The image sequence is assigned to the well of the deposited cell and stored for documentation. Viability Our instruments gentle handling routinely achieves high cell viability without the need for cell labelling. Purity A disposable cartridge is the only component in contact with the cells ensuring no cross-contamination between samples and no cleaning routines. Easy to use and flexible Our instruments and software are intuitive, user friendly, and can be readily implemented into existing structures and workflows. Interested in joining our team? cytena is a young, dynamic and highly motivated team. We are looking for new team members who also have interest in developing new and innovative products. Feel free to contact us if you have any inquiries on current open positions.
51 to 200 staff
Definiens, The Tissue Phenomics Company
We improve patient lives by unlocking the tissue phenome. In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer. Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit:
51 to 200 staff
Ecolab Life Sciences
Ecolab Life Sciences offers unparalleled cleaning and advanced contamination control expertise to pharmaceutical and personal care manufacturers across the globe. We deliver more than quality cleaning chemistry. We bring enhanced value to customers, helping optimize production performance and mitigate risk. Enhanced value: Our expertise applied to our cleaning and advanced contamination control solutions means customers have access to a comprehensive portfolio of high-quality cleaning and disinfection chemistry, equipment, and Bioquell vaporized hydrogen peroxide decontamination. Optimized production performance: Our expertise across a wide range of critical manufacturing applications helps customers move toward maximum production uptime and productivity. Mitigated risk: Our expertise and global scale applied across our customers’ contamination-control operations help assist with business continuity through the worldwide availability of our solutions and knowledge of region-specific quality and regulatory requirements.
201 to 500 staff
Irubis
IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing. IRUBIS develops advanced Process Analytical Technology (PAT) tool based on mid-infrared (MIR) spectroscopy to bring intelligence to biopharmaceutical manufacturing. Its flagship product, Monipa, with single-use capabilities delivers inline, real-time concentration data for proteins, excipients, and nucleic acids—empowering faster decision-making, reducing batch loss, and simplifying bioprocess development and scale-up. Read more about our products and innovations at
11 to 50 staff
Microcoat Biotechnologie Gmbh
Microcoat offers a wide range of individual and specialized services for the diagnostic and pharmaceutical industry. In close cooperation with our customers, we aim for best performance building on a complete range of advanced technologies and uncompromised quality standards. For pharmaceutical companies, we leverage our profound expertise in vitro diagnostics and assay development in order to become a preferred partner in early development, preclinical and clinical phases of drug development and patient monitoring. For food safety, environmental testing and other specialized diagnostic fields, Microcoat aims to be the preferred OEM-partner for the development and manufacturing of reliable test components and kits. Irrespective of what your individual needs and requirements are, benefit from the synergies of our broad method, technology and product portfolio and the in-depth know-how within our three business areas- Custom Development - Contract Manufacturing - Laboratory Services
201 to 500 staff
Receptor.Ai
Receptor.AI is a TechBio drug discovery company that combines a multi-platform AI ecosystem with a modality-agnostic decision engine to define the right therapeutic strategy and design the right molecule to address complex target biology. Our ecosystem integrates small molecules, peptides, and induced-proximity therapeutics, enabling objective comparison and selection of drug discovery approaches. This allows us to design molecules that align with strategic program direction and increase the probability of clinical success. We partner with pharma and biotech organizations to advance high-confidence programs toward the clinic, with capabilities validated across 40+ discovery programs and guided by experts behind FDA-approved and clinical-stage medicines.
51 to 200 staff
Resolve Biosciences
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.
51 to 200 staff
Sartorius Cellgenix Gmbh
Sartorius CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. We wanted to share that we will not be actively posting or engaging on this LinkedIn account. However, you can continue to stay updated and connect with us over at We appreciate all the conversations and connections we’ve built here and look forward to continuing them on our other page. Thank you for your support, and we hope to see you there!
51 to 200 staff
Sphingotec
SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. SphingoTec GmbH was established in 2002 by Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible for the development of the “gold standard” sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™).
11 to 50 staff
Stemcell Technologies
STEMCELL Technologies is a Canadian biotechnology company that helps power leading-edge life science research around the world. Driven by our love of science and passion for quality, we are Scientists Helping Scientists—standing by our customers to provide the outstanding products, technical support, and training they need to advance their research. Scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, accessory products, and services. Since the launch of the company by Dr. Allen Eaves in 1993, STEMCELL has reinvested all profits back into the research and development of products to better support the international research community. Today, STEMCELL is the largest biotech company in Canada, with over employees globally, most with scientific or engineering degrees. Through our many regional offices, as well as our distribution centers in Vancouver, Seattle, Grenoble, and Singapore, we deliver our innovative, specialized products to more than 70 countries. At STEMCELL, we are dedicated to improving lives through advancing knowledge and scientific discovery, through our commitment to fostering diversity and inclusion in STEM and the life sciences industry, and through our investments in sustainability, community, and social responsibility. We do all this because we love science as much as you do.#ScientistsHelpingScientists
1001 to 5000 staff
Traceless Materials
We are traceless - a circular bioeconomy scale-up producing a new class of materials designed to leave no trace. With our patented process, we transform agricultural residues into traceless® materials: biobased on leftovers, plastic-free, home-compostable, and climate-friendly. Our goal is clear: to replace plastics at scale and build a net-zero, circular materials industry. Our solution is designed for brands and converters seeking truly sustainable alternatives to plastic in packaging and single-use products — with the performance they know and expect. traceless® runs on existing processing lines and delivers the functionality the industry needs, without the environmental footprint. Founded in 2020, we’ve grown into a 100-person team, raised a €36.6M Series A, and are currently building our first large-scale production facility in Hamburg, Germany — launching at the end of 2025. The next step: commercial market entry. Follow us to stay connected and learn more at Industry focus: bioeconomy, materials science, packaging, plastic alternatives, circular economy Specialties: new materials, biomaterials, material innovation, industrial scale-up, bioeconomy, biobased materials
51 to 200 staff
Tron-Mainz
Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics and immunology to identify “omics”-based biomarkers and develop personalized therapies. Partnering with academia and industry, we conduct ground-breaking research to support innovative drug design for human health.
51 to 200 staff
Basf Metabolome Solutions Gmbh
BASF Metabolome Solutions GmbH is the expert service provider of mass spectrometry-based Biological Analytics for customers within and outside of BASF. We passionately deliver a wide variety of analytics-services for R&D and regulation of chemical products. With approximately 50 highly skilled employees we dedicate more than 24 years of expertise to your projects, including Metabolite Profiling, targeted analytics, plant services and know how in metabolism, biomarkers and chemical mode of actions. Operations are compliant with Good Laboratory Practice (GLP) enabling a variety of services for regulatory studies of chemicals and biotech products.
11 to 50 staff
Bioecho Life Sciences
BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market - in just one single step. It reduces the associated plastic consumption by up to 70 %. Customers in molecular diagnostics, academic and biopharmaceutical research, plant and animal breeding rely on our products: ready-to-use kits, high-throughput solutions for automation platforms, nucleic acid extraction services and process optimization for molecular biology laboratories. BioEcho, located in Cologne, Germany, was founded in 2016 by leading industry experts and is certified according to ISO 9001 and ISO 13485. During the pandemic, our Viral RNA/DNA Swab kit was used in up to 15 % of Covid PCR tests in Germany and 50 % of tests in Austria. Through our European direct Sales team, our global distributor network, and our international online shop we serve a worldwide growing customer base with best-in-class products and services. BioEcho. The Nucleic Acid Experts. Follow us on LinkedIn so that we can keep you posted and get in touch via contact@bioecho.de.
11 to 50 staff
Biogenes Gmbh
BioGenes is a full-service provider of customized immunoassay and antibody development, with a strong commitment to quality and service. Founded in 1992 and headquartered in Berlin, Germany, BioGenes is a recognized partner serving more than 600 customers in 40 countries. The company maintains long-term relationships with global pharmaceutical, biotech companies, CMOs and in vitro diagnostic firms. BioGenes provides highly customized solutions for the quality control of biological products, from drug discovery and drug development to the manufacturing of biologicals, as well as for diagnostic purposes. The company specializes in sophisticated custom monoclonal, polyclonal and anti-idiotypic antibody development and has a proven track record in the development, optimization, pre-validation and production of highly sensitive and robust ELISAs and host cell protein (HCP) assays. Furthermore, BioGenes offers the enhanced generic 360-HCP ELISA kits and supports customers with a comprehensive range of analytical services.
51 to 200 staff
Byonoy
At Byonoy, we do pioneering work to simplify your lab's workflow. We create more intuitive, flexible, and compact instruments than traditional massive devices, performing their job unequivocally. Powered with highly functional design and intuitive user interfaces, our devices allow you to focus on your application, not the tools. The affordability of our instruments also allows the latest measurement technology within reach of researchers. To guarantee our high-quality standards, we perform all the essential steps of development and production in-house. Do you share our pioneering spirit and would like to experience the future of the laboratory? Then contact us or book a free demo!
11 to 50 staff
Cryotherm
Welcome to Cryotherm! We are the specialists for the construction and manufacturing of vacuum super insulated containers and transfer pipes for cryogenic liquid gases that are used in many different industries such as food industry, chemical facilities, medicine, research or biotechnology. We develop innovative and market-oriented solutions for our customers' individual processes.
51 to 200 staff
Dynamic42 Gmbh
We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling.
11 to 50 staff
